Mapa mental
CKD

Mind map: CKD (chronic kidney disease)
Conteúdo do mapa
CKD
Causes
- HTN
- Diabetes
- Age related decline
- Glomerulonephritis
- PKD
- Medications - NSAIDS, PPIs, lithium
RFs
- Older age
- Diabetes
- HTN
- Smoking
- Nephrotoxic meds
Presentation
- Usually asymptomatic
- Pruritus
- Loss of appetite
- Nausea
- Oedema
- Muscle cramps
- Peripheral neuropathy
- Pallor
- HTN
Ivx
- eGFR - 2 tests required 3 months apart
- Proteinuria - ACR >3mg/mmol
- Haematuria - should prompt investigation for malignancy
- Renal USS - Accelerated CKD, haematuria, FH of PKD or evidence of obstruction
Stages
- G1 = >90 G2 = 60-89 G3a= 45-59 G3b= 30-44 G4 = 15-29 G5 = <15
- A1 = < 3mg/mmol A2 =3 – 30mg/mmol A3= > 30mg/mmol
- G1 = >90 G2 = 60-89 G3a= 45-59 G3b= 30-44 G4 = 15-29 G5 = <15
Complications
- Anaemia
- Renal bone disease
- CVD
- Peripheral neuropathy
- Dialysis related problems
Referral to a Specialist
- eGFR < 30
- ACR ≥ 70 mg/mmol
- Accelerated progression (↓in eGFR of 15 or 25% or 15 ml/min in 1 year)
- Uncontrolled HTN despite ≥ 4 antihypertensives
Management
- Slowing progression
- Optimise diabetic control
- Optimise hypertensive control
- Treat glomerulonephritis
- Reducing risk of complications
- Exercise, maintain healthy weight, stop smoking
- Special dietary advice about phosphate, sodium, potassium, water intake
- Offer atorvastatin 20mg
- Treating complications
- Oral sodium bicarbonate - metabolic acidosis
- Iron supplementation, erythropoietin - anaemia
- Vitamin D - renal bone disease
- Dialysis - end stage renal failure
- Renal transplant
- Slowing progression
Anaemia of Chronic Kidney Disease
- Oral iron > IV iron > erythropoetin
Renal Bone Disease
- Features
- Osteomalacia Osteoporosis Osteosclerosis
- x-ray
- "Rugger jersey” spine
- Management
- Active forms of vitamin D (alfacalcidol & calcitriol)
- Low phosphate diet
- Bisphosphonates
- Features
Informações
- Descrição
- Surgery Medicine (Renal) Mapa Mental sobre CKD, criado por liba aysha em 20-01-2020.
- Criado por
- liba aysha
- Visualizações
- 0
- Avaliação